Radiation-induced Oral Mucositis Clinical Trial
Official title:
Clinical Study of the Effects of Compound Kushen Injection on Radiation-induced Oral Mucositis in Head and Neck Cancer Patients.
Oral mucositis (OM) is an acute side effect of radiotherapy for head and neck cancer (HNC). OM associated pain affects oral functions and nutrition of the patient that may result in discontinuity of treatment.The purpose of this clinical study is to evaluate the therapeutic effects of Compound Kushen Injection (CKI) on oral mucositis caused by radiotherapy of head and neck cancer.
Patients with oral mucositis caused by radiotherapy for Head and Neck Cancer,will be enrolled in the trial, then seprated randomly in two group,the experimental group treated with Levofloxacin injection plus CKI; the contral group treated with Levofloxacin injection only. Clinical grade of radioactive oral mucositis,Oral pain score,Completion and duration of interruption of radiotherapy, Completion of chemotherapy during concurrent chemoradiotherapy,weight change,Food intake (liquid food, semi liquid food),recovery time of oral mucositis will be compared before treatment, 3 days, 5 days and 7 days after treatment between the experimental group and the control group. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04110977 -
A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer
|
N/A | |
Recruiting |
NCT05893810 -
Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis
|
Phase 3 |